Pages that link to "Q38017728"

The following pages link to Intraocular pressure-lowering combination therapies with prostaglandin analogues (Q38017728):

Displaying 10 items.

• Management of glaucoma in pregnancy: risks or choices, a dilemma? (Q28068244) (← links)
• Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma (Q38166800) (← links)
• Efficacy and safety of tafluprost 0.0015% and timolol maleate 0.5% fixed combination in patients with ocular hypertension or open-angle glaucoma (Q38244537) (← links)
• Tafluprost/Timolol: A Review in Open-Angle Glaucoma or Ocular Hypertension (Q38598001) (← links)
• Are preservatives necessary to improve efficacy of some glaucoma drops? (Q44839882) (← links)
• Long-term Follow-up of Patients receiving Intraocular Pressure-lowering Medications as Cataract Surgery Candidates: A Case-control Study. (Q47104053) (← links)
• Beta2 adrenergic receptor silencing change intraocular pressure in New Zealand rabbits. (Q48602585) (← links)
• Netarsudil Ophthalmic Solution 0.02%: First Global Approval (Q49908942) (← links)
• Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension. (Q55022142) (← links)
• New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost (Q91152106) (← links)